Skip to main content
Caplight Logo









Xironetic

Xironetic

Private
Oklahoma City, OklahomaHealthcare & Life Scienceshttps://www.xironetic.com/

Last Round

Grant

May 9, 2024

Total Funding Raised

$148,091

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Xironetic is a healthcare technology company that provides an FDA-cleared augmented reality platform, IntraOpVSP, which uses AI and computer vision to project holographic overlays onto a patient during surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, AR/VR Experiences, Computer Vision, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

surgical augmented realitysurgical visualizationholographic surgerycomputer visionmedical ARsurgical guidancemixed reality surgeryFDA-cleared softwaremedical imagingvirtual surgical planningVSPoperating room techsurgical navigationmedical SaaSdigital surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xironetic Comparables

Compare Xironetic with similar companies based on industry and business-model similarity.

Xironetic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medivis
87%
MediView XR, Inc.
85%
EchoPixel, Inc.
81%

Xironetic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 9, 2024
AcceleratorJan 1, 2023

Key People

Founding team and executive leadership

Jeffrey Potts

Chief Technology Officer

Executive Team

Brandon Strong

Chief Research Officer (CRO) & Chief Product Officer (CPO)

Executive Team

Xironetic Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 29, 2026

    Grew 50% QoQ, from 8 to 12 employees.

  • May 9, 2024

    $148K grant received from government agencies.

Xironetic Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xironetic Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xironetic's valuation, stock price, and market status.

Firmographic Details

HeadquartersOklahoma City, Oklahoma
Employee Range12
Year Founded2021
Last FundingMay 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?